Gainers
- Klotho Neurosciences KLTO stock increased by 617.5% to $1.47 during Monday's regular session. The market value of their outstanding shares is at $47.7 million.
- Citius Pharmaceuticals CTXR shares rose 121.5% to $1.89. The company's market cap stands at $19.3 million.
- NuCana NCNA stock rose 77.15% to $0.09.
- Know Labs KNW shares increased by 75.32% to $2.73. The company's market cap stands at $20.5 million.
- Synaptogenix SNPX stock rose 33.6% to $3.22. The market value of their outstanding shares is at $4.4 million.
- Fractyl Health GUTS shares rose 32.78% to $2.64. The company's market cap stands at $129.4 million.
Losers
- Reshape Lifesciences RSLS stock declined by 40.2% to $2.5 during Monday's regular session. The company's market cap stands at $1.8 million.
- Nuwellis NUWE shares decreased by 39.85% to $0.24. The company's market cap stands at $1.0 million.
- Meihua Intl Medical Techs MHUA shares fell 29.89% to $0.42. The company's market cap stands at $10.6 million.
- Helius Medical Tech HSDT stock fell 22.94% to $0.84.
- ModivCare MODV shares declined by 18.74% to $3.21. The market value of their outstanding shares is at $46.0 million.
- Lyra Therapeutics LYRA shares fell 18.68% to $19.75. The market value of their outstanding shares is at $26.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CTXRCitius Pharmaceuticals Inc
$0.7862-10.1%
Edge Rankings
Momentum
1.94
Price Trend
Short
Medium
Long
GUTSFractyl Health Inc
$2.03-1.46%
HSDTHelius Medical Technologies Inc
$0.4553-10.6%
KLTOKlotho Neurosciences Inc
$1.8113.1%
KNWKnow Labs Inc
$3.424.27%
LYRALyra Therapeutics Inc
$11.19-1.36%
MHUAMeihua International Medical Technologies Co Ltd
$0.3403-0.12%
MODVModivCare Inc
$3.033.77%
NCNANuCana PLC
$0.139521.4%
NUWENuwellis Inc
$0.28441.90%
RSLSReshape Lifesciences Inc
$2.45-2.78%
SNPXSynaptogenix Inc
$4.0910.2%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in